Kamada Ltd

KMDANASDAQUSD
7.71 USD
0.32 (3.93%)AT CLOSE (11:59 AM EDT)
7.99
0.28 (3.67%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
7.99
0.28 (3.67%)
🔴Market: CLOSED
Open?$8.00
High?$8.00
Low?$7.71
Prev. Close?$8.03
Volume?65.8K
Avg. Volume?45.5K
VWAP?$7.82
Rel. Volume?1.45x
Bid / Ask
Bid?$7.59 × 200
Ask?$8.40 × 100
Spread?$0.81
Midpoint?$8.00
Valuation & Ratios
Market Cap?444.8M
Shares Out?N/A
Float?31.4M
Float %?54.6%
P/E Ratio?N/A
P/B Ratio?6.66
EPS?-$0.05
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Employees
462
Market Cap
444.8M
Industry
N/A
Listed
2013-05-31
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.83Strong
Quick Ratio?1.89Adequate
Cash Ratio?0.37Low
Debt/Equity?0.03Low
ValuationFAIRLY VALUED
Score
58/100
P/E?
N/A
P/B?
6.66FAIR
P/S?
7.47HIGH
P/FCF?
N/A
EV/EBITDA?
-6,614.7CHEAP
EV/Sales?
7.33HIGH
Returns & Efficiency
ROE?
-4.3%WEAK
ROA?
-2.9%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$436.6M
Fundamentals ratios updated end of day